查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433394

全球皮肤切片市场 2023-2030

Global Skin Biopsy Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030年），全球皮肤切片市场将以6.8%的复合CAGR成长。市场的成长归因于对先进护肤产品的需求。消费者对高品质护肤产品的需求持续成长，尤其是那些采用科学验证的显着成分（如透明质酸、胜肽和抗氧化剂）设计的产品。新产品的推出激发了护肤界的兴趣和调查。例如，2022年12月，Hydrinity Accelerated Skin Science推出了新的脸部护肤系列，其中含有众所周知的透明质酸（HA）成分、PPM技术以及多种胜肽和抗氧化剂。新的护肤系列包括更新的透明质酸精华液、保湿和修復精华液，以及轻盈、有益于微生物组的净化喷雾，所有这些都旨在减少衰老迹象、改善肤质并加速皮肤癒合。然而，皮肤活检的高成本可能会限制其在低收入经济体的成长。

细分市场前景

全球皮肤切片市场按类型、适应症和最终用户进行细分。根据类型，市场分为刮取活检、穿刺活检和切除活检。根据适应症，市场细分为皮肤癌诊断和分期、光化性角化病、皮肤炎等。此外，根据最终用户，市场细分为医院、诊断实验室等。皮肤癌诊断和分期子类别预计将占据适应症领域的很大一部分市场份额。这种增长可归因于皮肤癌盛行率的增加，以及皮肤病的诊断较早。此外，皮肤癌需要尽快检测和治疗，以避免在危险的黑色素瘤或其他皮肤癌的情况下需要手术。

诊断实验室细分市场预计将在全球皮肤活检市场中占据相当大的份额

在最终用户中，诊断实验室细分市场预计将在全球皮肤活检市场中占据相当大的份额。细分市场的成长归功于创新的诊断方法。使用皮肤切片样本诊断阿兹海默症是神经学领域的创新方法。这些创新方法拓宽了皮肤活检在皮肤科以外的应用，有助于皮肤活检行业的多元化。例如，2023年2月，SynapsDx准备推出基于皮肤的阿兹海默症诊断测试​​。 Synaps 使用三种生物标记来诊断阿兹海默症并将其与其他痴呆症类型区分开来。主要诊断基于形态测量成像，该成像测量患者皮肤样本中成纤维细胞的细胞生长。阿兹海默症患者的大聚集体较少。

区域展望

全球皮肤切片市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本） 、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于皮肤健康意识的增强，预计亚太地区将在全球市场中占据显着份额，预计诊断和治疗过程将在整个预测期内推动市场发展。

考虑到全球皮肤活检市场，北美保持不变

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Cardinal Health, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Becton, Dickinson, and Co.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Bio-Rad Laboratories, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展

第 4 章：市场细分

  • 按类型分類的全球皮肤活检市场
    • 刮取活检
    • 穿刺活检
    • 切除活检
  • 按适应症分類的全球皮肤切片市场
    • 皮肤癌的诊断和分期
    • 光化性角化症
    • 皮肤炎
    • 其他（头髮和指甲疾病以及自体免疫性皮肤疾病）
  • 按最终用户分類的全球皮肤活检市场
    • 医院
    • 诊断实验室
    • 其他（研究机构和学术中心、皮肤科医生和病理学家）

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • AccuTec, Inc.
  • Danaher Corp.
  • Hologic, Inc.
  • Innovia Medical
  • Integra LifeSciences
  • Jai Surgicals Ltd.
  • Kai Corp.
  • NIKON CORP.
  • Paramount Surgimed Ltd.
  • PerkinElmer U.S. LLC
  • Roche Diagnostics India Pvt. Ltd.
  • Stryker Corp.
  • Thermo Fisher Scientific Inc.
  • Vernacare
  • World Precision Instruments
  • Sysmex Corp.
  • Bruker Corp.
  • Illumina, Inc.
Product Code: OMR2027970

Global Skin Biopsy Market Size, Share &Trends Analysis Report by Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), by Indication (Skin Cancer Diagnosis and Staging, Actinic keratosis, Dermatitis, and Others) and by End-User (Hospitals, Diagnostic Laboratories, and Others), Forecast Period (2023-2030)

The global skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030).The market's growth is attributed to the demand for advanced skincare products. Consumer demand for high-quality skincare products, particularly those designed with prominent and scientifically validated components such as HA, peptides, and antioxidants, continues to rise. The launch of new products stimulates interest and investigation in the skincare sector. For instance, in December 2022, Hydrinity Accelerated Skin Science launched new facial skin care line with well-known ingredients of hyaluronic acid (HA), PPM technology, and numerous peptides and antioxidants. The new skin care line includes a renewing HA serum, a hydrating and healing serum, and a lightweight, microbiome-friendly purifying mist, all designed to reduce signs of aging, improve texture, and accelerate skin healing. However, the high cost of skin biopsy may restrain its growth in low-income economies.

Segmental Outlook

The global skin biopsy market is segmented on the type, indication, and end-user. Based on the type, the market is sub-segmented into shave biopsy, punch biopsy, and excisional biopsy. Based on the indication, the market is sub-segmented into skin cancer diagnosis and staging, actinic keratosis, dermatitis, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals, diagnostic laboratories, and others. The skin cancer diagnosis and staging subcategory is expected to capture a significant portion of the market share within the indication segment. The growth can be attributed to the skin cancer prevalence is increasing, and skin diseases have been diagnosed earlier. In addition, skin cancer needs to be detected and treated as soon as possible to avoid the need for surgery in the case of a dangerous melanoma or other skin cancer.

Diagnostic Laboratories Sub-Segment is Anticipated to Hold a Considerable Share of the global Skin Biopsy Market

Among the end-user, the diagnostic laboratories sub-segment is expected to hold a considerable share in the global Skin Biopsy market. The segmental growth is attributed to the innovative diagnostic approaches. The use of skin biopsy samples to diagnose Alzheimer's disease is an innovative method in neurology. Such innovative approaches broaden the applications of skin biopsies outside dermatology, helping to diversify the skin biopsy industry. For instance, in February 2023, SynapsDx Prepares Launched Skin-Based Alzheimer's Disease Diagnostic Test. Synaps uses three biomarkers to diagnose Alzheimer's disease and differentiate it from other dementia forms. The primary diagnosis is based on morphometric imaging, that measures cell growth in fibroblasts from a patient's skin sample. Alzheimer's patients have fewer large aggregates.

Regional Outlook

The global skin biopsy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increased awareness of skin health, diagnosis, and treatment processes is expected to drive the market throughout the forecast period.

The North America Holds Considering the global Skin Biopsy Market

Regional growth is attributed to the medical need for pediatric skin biopsies. The observations highlight the importance of skin biopsies in the diagnosis of pediatric skin disorders. As a result children and adolescents account for a sizable proportion of biopsy cases, the demand for biopsy equipment and services tailored to younger patients has the potential to drive market expansion.

According to the National Institute of Government, in June 2023, a study analyzed 1308 biopsy records, revealing a male predominance and a majority of patients were adolescents. Furthermore, study found that 12.9% of pediatric skin biopsies were performed, with 83.9% of patients underwent a single biopsy. The majority of patients underwent multiple biopsies, with 98% performing a biopsy for diagnostic purposes. The mean age of patients was 12 years, with males outnumbering females. The study emphasizes the importance of skin biopsies in pediatric patients and the high clinic-histopathologic agreement. Leprosy and papulosquamous diseases were the most common cases.

Market Players Outlook

The major companies serving the skin biopsy market includes Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

For instance in June 2019,Proscia Launched DermAI to Pre-Screen and Classify Skin Biopsies. Proscia's AI-powered software can classify skin disease variants into pre-diagnostic categories, enhancing pathology confidence, quality, and speed, reducing errors and improving laboratory efficiency.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global skin biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Cardinal Health, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton, Dickinson, and Co.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Bio-Rad Laboratories, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments

4. Market Segmentation

  • 4.1. Global Skin Biopsy Market by Type
    • 4.1.1. Shave Biopsy
    • 4.1.2. Punch Biopsy
    • 4.1.3. Excisional Biopsy
  • 4.2. Global Skin Biopsy Market by Indication
    • 4.2.1. Skin Cancer Diagnosis and Staging
    • 4.2.2. Actinic Keratosis
    • 4.2.3. Dermatitis
    • 4.2.4. Others (Hair and Nail Disorders, and Autoimmune Skin Disorders)
  • 4.3. Global Skin Biopsy Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostic Laboratories
    • 4.3.3. Others (Research Institutions and Academic Centers, Dermatologists and Pathologists)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AccuTec, Inc.
  • 6.2. Danaher Corp.
  • 6.3. Hologic, Inc.
  • 6.4. Innovia Medical
  • 6.5. Integra LifeSciences
  • 6.6. Jai Surgicals Ltd.
  • 6.7. Kai Corp.
  • 6.8. NIKON CORP.
  • 6.9. Paramount Surgimed Ltd.
  • 6.10. PerkinElmer U.S. LLC
  • 6.11. Roche Diagnostics India Pvt. Ltd.
  • 6.12. Stryker Corp.
  • 6.13. Thermo Fisher Scientific Inc.
  • 6.14. Vernacare
  • 6.15. World Precision Instruments
  • 6.16. Sysmex Corp.
  • 6.17. Bruker Corp.
  • 6.18. Illumina, Inc.

LIST OF TABLES

  • 1. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL EXCISIONAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SKIN BIOPSY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SKIN BIOPSY MARKET SHARE BY INDICATION, 2022 VS 2030 (%)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SKIN BIOPSY MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)